WHEN medical cannabis became legal in Australia in 2017, you could be forgiven for thinking it would allow patients with a range of serious illnesses and chronic pain access to a medicine they felt could help them.
“That’s a reasonable assumption to make,” says Rhys Cohen, senior project officer from University of Sydney’s Lambert Initiative for Cannabinoid Therapeutics.
“And I think that’s the assumption many politicians have made as well. ‘OK, you know, we’ve fixed medical cannabis, what’s next’?”
The reality, though, is much different.
For more of this story, purchase your copy of Saturday's Sunraysia Daily 30/03/2019. To subscribe to our Digital Edition Click here